LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,942 | -98.1% | 282 | -98.0% | 0.00% | -97.0% |
| Q2 2023 | $979,328 | +1920151.0% | 14,187 | +1248.6% | 0.03% | +1550.0% |
| Q1 2023 | $51 | -25.0% | 1,052 | -22.6% | 0.00% | -33.3% |
| Q4 2022 | $68 | -100.0% | 1,360 | -66.9% | 0.00% | 0.0% |
| Q3 2022 | $167,000 | -52.8% | 4,106 | -36.3% | 0.00% | -62.5% |
| Q2 2022 | $354,000 | +653.2% | 6,442 | +402.5% | 0.01% | – |
| Q1 2022 | $47,000 | +30.6% | 1,282 | +63.9% | 0.00% | -100.0% |
| Q4 2021 | $36,000 | +140.0% | 782 | +167.8% | 0.00% | – |
| Q3 2021 | $15,000 | -28.6% | 292 | -44.0% | 0.00% | -100.0% |
| Q2 2021 | $21,000 | -48.8% | 521 | -63.0% | 0.00% | 0.0% |
| Q1 2021 | $41,000 | -78.2% | 1,407 | -79.0% | 0.00% | -83.3% |
| Q4 2020 | $188,000 | +9300.0% | 6,699 | +9470.0% | 0.01% | – |
| Q3 2020 | $2,000 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |